Article and Video CATEGORIES

Cancer Journey

Search By

Amy brings over three decades of experience in for-profit and nonprofit business management and ownership. In December 2017, she joined The Global Resource for Advancing Cancer Education as its Executive Director. She directs its growth in strategy, revenue, outreach, partnership, and programs.

 

2024 Featured Programs
Featured Programs for 2024
Author
Amy Bickleman
Image
Grace Patient Education Programs 2024

Next Previous link

Previous PostNext Post

Related Content

Image
Blood Cancers OncTalk
Article
Registration is now open! Join us for the annual 2024 Blood Cancers OncTalk!  Register Now!
Image
PEA 2024-25 final
Article
GRACE is pleased to announce the acceptance of five rising stars into the 6th year of the GRACE Patient Education Ambassadors Program for the 2024-25 Program Year! 
Image
2024 patient education ambassadors program
Article
Applications are now open to oncology fellows and finishing fellows Program Information Form and Application

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on